manufacturer

Cutting the risks of injury and contamination

Austrian firm Greiner Bio-One is presenting products for the pre-analysis and diagnostics industry at this year’s Medica. Vacuette safety products have been developed to minimise this risk of injuries from contaminated puncture devices – a significant safety hazard to healthcare workers, the firm underlines.

The Vacuette Quickshield Safety Tube
Holder
The Vacuette Quickshield Safety Tube Holder

‘Special product solutions, such as the Vacuette Quickshield Safety Tube Holder with 360° rotatable safety shield, or the Vacuette Premium Blood Collection Tubes with safety screw cap, reduce the risk of injury or contamination to an absolute minimum.’ For rapid identification of nosocomial infections, Greiner Bio-One developed Genspeed, a molecular diagnostics system that combines crude lysis of bacteria with multiplex PCR followed by automated analysis of PCR products in the new Genspeed R2 analyser.

‘The Genspeed Test System stands out in terms of speed and high sensitivity,’ the manufacturer points out. ‘Analyses of individual samples can be made at any time. The three controls (for DNA amplification, hybridisation, as well as a negative control) on the Test Chip guarantee maximum reliability.’ The system is also reported to be compact and maintenance-free and easy to use. ‘Pre-filled reagents and the automated Genspeed R2 analyser reduce the number of process steps to a minimum,’ Grenier Bio-One adds about this newly available in Europe product. ‘One example is the Genspeed MRSA Test, a DNA-based, in-vitro, diagnostic tool for the qualitative detection of MRSA within 75 minutes from human nasal and pharyngeal smears. It features the detection of the two relevant resistance genes, mecA and mecC.’

 

Greiner Bio-One is at Medica 
Hall 03 / Stand G60

10.11.2014

More on the subject:

Related articles

Photo

News • Improved infection protection

S. aureus: One step closer to a vaccine

Staphylococcus aureus is a leading cause of hospital-acquired bacterial infection, associated with over one million deaths worldwide each year. Now, researchers could be one step closer to a vaccine.

Photo

News • Evolution and host-specific adaptation

Pseudomonas aeruginosa: origins of an epidemic pathogen

How do pathogenic bacteria evolve to become epidemic? To find out, researchers examined DNA data from almost 10,000 samples taken from infected individuals, animals, and environments around the world.

Photo

News • Tracking the spread and evolution of superbugs

Mapping the movement of people (and their pathogen travel companions)

Integrating bacterial genomic data with detailed human mobility data makes it possible to see how pathogens causing pneumonia and meningitis, move between regions and evolve over time.

Subscribe to Newsletter